×

ROCHE AND ABBVIE'S VENCLEXTA PLUS RITUXAN LEADS TO SIGNIFICANTLY LONGER PFS THAN TREANDA/RITUXAN - INTERIM PHASE III STUDY DATA

ROCHE AND ABBVIE'S VENCLEXTA PLUS RITUXAN LEADS TO SIGNIFICANTLY LONGER PFS THAN TREANDA/RITUXAN - INTERIM PHASE III STUDY DATA